Executive record

Mr. D'Silva

Most recent record: OptimizeRx Corporation CFO transition: Mr. D'Silva to succeed Edward Stelmakh (named as the incoming officer), effective January 1, 2027. See OptimizeRx Corporation.

1 verified record

This page lists only verified filing records that name Mr. D'Silva; it is not a career history. Corrections: the corrections page.